IOVA SECURITIES NEWS: A Class Action was filed against Iovance Biotherapeutics, Inc. after 44% Stock Drop; Contact BFA Law befor

  • NEW YORK, NY / ACCESSWIRE / May 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit.